Clinical Trial Update: An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial evaluating the safety, tolerability, efficacy, and pharmacokinetic profile of tacrolimus inhalation powder in adult lung transplant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplant Rejection

Drugs mentioned

• Tacrolimus inhalation powder (Tacrolimus)

Snippet

Sponsor: TFF Pharmaceuticals, Inc. | Conditions: Lung Transplant Rejection | Phase 2 | Status: TERMINATED